Clinical Drug Experience Knowledgebase

Anus Neoplasms (Phase 1)

Blast Crisis (Phase 1)

Breast Neoplasms (Phase 1)

Carcinoma (Phase 1)

Carcinoma, Basal Cell (Phase 1)

Carcinoma, Neuroendocrine (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 1)

Carcinoma, Squamous Cell (Phase 1)

Cholangiocarcinoma (Phase 1)

Colorectal Neoplasms (Phase 1)

Conjunctivitis (Phase 1)

Conjunctivitis, Allergic (Phase 1)

Dermatitis (Phase 1)

Dermatitis, Atopic (Phase 1)

Digestive System Neoplasms (Phase 1)

Eczema (Phase 1)

Endometrial Neoplasms (Phase 1)

Fallopian Tube Neoplasms (Phase 1)

Gastrointestinal Neoplasms (Phase 1)

Histiocytoma, Malignant Fibrous (Phase 1)

Hodgkin Disease (Phase 1)

Immunoglobulin G4-Related Disease (Phase 2)

Leukemia (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Lung Neoplasms (Phase 1)

Lupus Erythematosus, Systemic (Phase 2)

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Lymphoma, Large-Cell, Anaplastic (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 1)

Mesothelioma (Phase 1)

Nasopharyngeal Carcinoma (Phase 1)

Neuroendocrine Tumors (Phase 1)

Ovarian Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Sarcoma (Phase 1)

Small Cell Lung Carcinoma (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Thymoma (Phase 1)

Triple Negative Breast Neoplasms (Phase 1)

Uterine Cervical Neoplasms (Phase 1)

Vulvar Neoplasms (Phase 1)